CD36 overexpression: A possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes
Diabetology & Metabolic Syndrome Aug 22, 2017
Lopez–Carmona MD, et al. – The physicians conducted this work to determine CD36 expression under different glycemic states in both healthy subjects and in atherosclerotic patients. It was showed that hyperglycemia is an important modulator of CD36 mRNA and non–glycated protein expression in vitro, increasing de novo synthesis in healthy subjects. There are progressive increases in CD36 receptors, which may be due to a post–translational stimulus in atherosclerotic patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries